Clinical Trials Directory

Trials / Completed

CompletedNCT04176666

NettOpp: The Development and Evaluation of an App-based Selective Intervention for Adolescents Exposed to Cyberbullying

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
709 (actual)
Sponsor
University of Tromso · Academic / Other
Sex
All
Age
11 Years – 16 Years
Healthy volunteers
Accepted

Summary

The aim of the project is to develop and evaluate an app-based intervention for adolescents who have been exposed to cyberbullying. The overarching goal is to offer a low-threshold intervention, called NettOpp, that is easy accessible and free to use for every junior high school student who has experienced cyberbullying in Norway.

Detailed description

The main aim of the intervention is to increase coping strategies for adolescents who have been exposed to cyberbullying. More specifically the aims are to increase 1) knowledge about cyberbullying, 2) help-seeking behavior, 3) coping strategies with cyberbullying, 4) to reduce mental health problems, and 5) cyberbullying, and 6) to increase self-esteem and the 7) sleeping quality of the adolescents. To evaluate the mobile application three studies will be conducted: A lab test, a pilot study, and a larger effectiveness study with a follow-up examination after 3 months. The lab test will be conducted to examine the quality of the prototype of the app in order to find out if adjustments have to be made. Thereafter, a pilot study will be conducted with adolescents that were exposed to cyberbullying in the past six months. The pilot study will use a pre-post design.The effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group.

Conditions

Interventions

TypeNameDescription
DEVICENettOppNettOpp is a mobile application for adolescents aged 11-16 years who have been exposed to cyberbullying or cyberaggression.

Timeline

Start date
2021-09-04
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2019-11-25
Last updated
2023-09-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04176666. Inclusion in this directory is not an endorsement.